228 related articles for article (PubMed ID: 26823699)
1. Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.
Mu DW; Guo HQ; Zhou GB; Li JY; Su B
Int J Clin Exp Pathol; 2015; 8(11):13864-70. PubMed ID: 26823699
[TBL] [Abstract][Full Text] [Related]
2. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
3. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
Choi J; Jo M; Lee E; Lee DY; Choi D
Fertil Steril; 2015 Sep; 104(3):655-64.e1. PubMed ID: 26051103
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
5. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway.
Shu J; Huang M; Tian Q; Shui Q; Zhou Y; Chen J
J Mol Histol; 2015 Apr; 46(2):157-71. PubMed ID: 25564356
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
He L; Guo S; Zhu T; Chen C; Xu K
Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
[TBL] [Abstract][Full Text] [Related]
8. Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.
Yuge K; Kikuchi E; Hagiwara M; Yasumizu Y; Tanaka N; Kosaka T; Miyajima A; Oya M
Mol Cancer Ther; 2015 Sep; 14(9):2112-20. PubMed ID: 26184482
[TBL] [Abstract][Full Text] [Related]
9. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
[TBL] [Abstract][Full Text] [Related]
10. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy.
Liu J; Zheng L; Ma L; Wang B; Zhao Y; Wu N; Liu G; Lin X
J Nutr Biochem; 2014 Nov; 25(11):1154-1160. PubMed ID: 25172632
[TBL] [Abstract][Full Text] [Related]
12. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
[TBL] [Abstract][Full Text] [Related]
13. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways.
Meng FD; Li Y; Tian X; Ma P; Sui CG; Fu LY; Jiang YH
Int J Clin Exp Pathol; 2015; 8(6):6157-68. PubMed ID: 26261493
[TBL] [Abstract][Full Text] [Related]
15. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses.
Riedl A; Schlederer M; Pudelko K; Stadler M; Walter S; Unterleuthner D; Unger C; Kramer N; Hengstschläger M; Kenner L; Pfeiffer D; Krupitza G; Dolznig H
J Cell Sci; 2017 Jan; 130(1):203-218. PubMed ID: 27663511
[TBL] [Abstract][Full Text] [Related]
17. β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
Yu X; Liao B; Zhu P; Cheng S; Du Z; Jiang G
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22863. PubMed ID: 34318533
[TBL] [Abstract][Full Text] [Related]
18. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
Parrales A; López E; Lee-Rivera I; López-Colomé AM
Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro effects of RAD001 on bladder cancer.
Vasconcelos-Nóbrega C; Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Brochado P; Cardoso ML; Palmeira C; Salvador A; Guedes-Teixeira CI; Colaço A; Palomino LF; Lopes C; Santos L; Oliveira PA
Urol Oncol; 2013 Oct; 31(7):1212-21. PubMed ID: 22169072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
